Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide (CGRP)-containing nerves in rat mesenteric arteries by Hobara, Narumi et al.
Human Anatomy & Physiology
Neuroscience
Okayama University Year 2008
Angiotensin II type 2 receptors facilitate
reinnervation of phenol-lesioned vascular
calcitonin gene-related peptide
(CGRP)-containing nerves in rat
mesenteric arteries
Narumi Hobara∗ Mitsuhiro Goda† Namika Yoshida‡
Shingo Takatori∗∗ Yoshihisa Kitamura††
Mitsunobu Mio‡‡ Hiromu Kawasaki§
∗Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama Univer-
sity
†Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama Univer-
sity
‡Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama Univer-
sity
∗∗Shujitsu University School of Pharmacy
††Department of Pharmaceutical Care and Health Sciences, Graduate School
of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University,
ykita@pheasant.pharm.okayama-u.ac.jp
‡‡Shujitsu University School of Pharmacy
§Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama Univer-
sity, kawasaki@pheasant.pharm.okayama-u.ac.jp
This paper is posted at eScholarship@OUDIR : Okayama University Digital Information
Repository.
http://escholarship.lib.okayama-u.ac.jp/neuroscience/2
Hobara et al  Page 1 
 
Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned 
vascular calcitonin gene-related peptide (CGRP)-containing nerves in rat 
mesenteric arteries 
 
 
Narumi Hobara a), Mitsuhiro Goda a), Namika Yoshida a), Shingo Takatori c), 
Yoshihisa Kitamura b), Mitsunobu Mio c) and Hiromu Kawasaki a) * 
 
 
a) Department of Clinical Pharmaceutical Science, Graduate School of 
Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 
1-1-1 Tsushima-naka, Okayama 700-8530, Japan 
 
b) Department of Pharmaceutical Care and Health Sciences, Graduate 
School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 
University, 1-1-1 Tsushima-naka, Okayama 700-8530, Japan  
 
c) Department of Pharmacology, Shujitsu University School of Pharmacy, 
1-6-1 Nishigawara, Okayama 703-8516, Japan 
 
 
 
Short title: AT2 receptor and reinnervation 
 
 
 
Address correspondence to: * Hiromu Kawasaki, Ph.D. 
Department of Clinical Pharmaceutical Science, Graduate School of 
Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 
1-1-1 Tsushima-naka, Okayama 700-8530, Japan 
Tel/Fax: +81-86-251-7970 
E-mail: kawasaki@pheasant.pharm.okayama-u.ac.jp 
 
Hobara et al  Page 2 
ABSTRACT 
The present study was designed to investigate involvement of angiotensin 
(Ang) II type 2 receptors (AT2 receptors) in restoration of perivascular 
nerve innervation injured by topical phenol treatment.  Male Wistar rats 
underwent in vivo topical application of 10% phenol around the superior 
mesenteric artery.  After phenol treatment, animals were subjected to 
immunohistochemistry of the third branch of small arteries, Western blot 
analysis of AT2 receptor protein expression in dorsal root ganglia (DRG) 
and studies of mesenteric neurogenic vasoresponsiveness.  Ang II (750 
ng/kg/day), nerve growth factor (NGF; 20 μg/kg/day) and PD123,319 (AT2 
receptor antagonist; 10 mg/kg/day) were intraperitoneally administered for 
7 days using osmotic mini-pumps immediately after topical phenol 
treatment.  Losartan (AT1 receptor antagonist) was administered in 
drinking water (0.025%).  Phenol treatment markedly reduced densities of 
both calcitonin gene-related peptide (CGRP)-like immunoreactivity (LI)- 
and neuropeptide Y (NPY)-LI-containing fibers.  NGF restored densities 
of both nerve fibers to the Sham control level.  Coadministration of Ang II 
and losartan significantly increased the density of CGRP-LI-fibers but not 
NPY-LI-fibers compared with saline control.  The increase of the density 
of CGRP-LI-fibers by coadministration of Ang II and losartan was 
suppressed by adding PD123,319.  Coadministration of Ang II and 
losartan ameliorated reduction of CGRP nerve-mediated vasodilation of 
perfused mesenteric arteries caused by phenol treatment.  The AT2 
receptor protein expression detected in DRG was markedly increased by 
NGF.  These results suggest that selective stimulation of AT2 receptors by 
Ang II facilitates reinnervation of mesenteric perivascular 
CGRP-containing nerves injured by topical phenol application in the rat. 
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It is generally accepted that angiotensin (Ang) II acts on two subtype 
receptors, which are Ang II type 1 (AT1) and Ang II type 2 (AT2) receptors.  
AT1 receptors mediate the main physiological actions of Ang II, including 
vasoconstriction, facilitation of sympathetic nerve function and 
enhancement of cell proliferation, while AT2 receptors have opposite 
physiological effects from those of AT1receptors, i.e., vasodilation, cell 
apoptosis and inhibition of cell proliferation (Nakajima et al., 1995; Stoll et 
al., 1995; Stroth et al., 1998).  Growth-promoting effects of Ang II have 
been shown to be mediated primary via AT1 receptors (Touyz and Schiffrin, 
1997).  However, AT2 receptors are involved in neuronal differentiation of 
PC12W cells (Meffert et al., 1996; Gallinat et al., 1997).  Furthermore, 
there is a growing body of evidence that stimulation of AT2 receptors 
promotes cell differentiation and regeneration in neuronal tissues (Gasparo 
et al., 2000; Reinecke et al., 2003).  AT2 receptors are drastically up 
regulated under conditions such as tissue injury (Viswanathan and Saavedra, 
1992) or sciatic nerve axotomy (Gallinat et al., 1998).  Several studies 
have suggested that Ang II, via the AT2 receptors, acts as a neurotrophic 
factor for peripheral neurons (Lucius et al., 1998; Reinecke et al., 2003). 
Perivascular nerves play an important role in the maintenance and 
regulation of vascular tone.  The mesenteric artery, which is part of a large 
vascular bed, has dense innervation of perivascular nerves such as 
sympathetic adrenergic vasoconstrictor nerves and non-adrenergic 
non-cholinergic calcitonin gene-related peptide (CGRP) containing nerves 
(CGRPergic nerves), which act as vasodilator nerves (Kawasaki et al., 1988, 
1990a).  Previous studies demonstrated that the innervation and function 
of CGRPergic nerves in mesenteric resistance arteries of spontaneously 
hypertensive rats (SHR) decrease with ageing to cause CGRPergic nerve 
remodeling (Kawasaki et al., 1990b; Kawasaki and Takasaki, 1992; 
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Kawasaki et al., 2001).  Furthermore, long-term treatment with AT1 
receptor antagonist prevents the CGRPergic nerve remodeling in SHR 
(Kawasaki et al., 2003; Hobara et al., 2005), implying that Ang II is an 
active substance that induces perivascular nerve remodeling via AT1 
receptors.  Thus, those studies led to the hypothesis that the restoration of 
CGRPergic nerve innervation after blockade of AT1 receptors in SHR 
might be due to stimulation of AT2 receptors, which exert a neurotrophic 
effect on the reinnervation. 
Recently, we demonstrated that innervation of CGRP- and neuropeptide 
Y (NPY)-containing adrenergic nerves in rat mesenteric resistance arteries 
was markedly reduced by topical application of phenol, and that nerve 
growth factor (NGF) facilitates reinnervation of both types of nerves 
(Hobara et al., 2006).  Therefore, the present study was designed to test 
the hypothesis that stimulation of AT2 receptors has the ability to facilitate 
reinnervation of mesenteric perivascular nerves after in vivo denervation 
induced by topical treatment with phenol (Hobara et al., 2006).  To 
stimulate AT2 receptors, Ang II was administered in the presence of an AT1 
receptor antagonist (losartan) after topical phenol treatment and innervation 
and functional changes in perivascular CGRP- or NPY-containing nerves in 
rat mesenteric resistance arteries were examined in this study. 
 
EXPERIMENTAL PROCEDURES 
 
Experimental animals 
Eight-week-old Wistar rats (purchased from Shimizu Experimental 
Animals, Shizuoka, Japan) were used in this study.  The animals were 
given food and water ad libitum.  They were housed in the Animal 
Research Center of Okayama University at a controlled ambient 
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temperature of 22°C with 50 ± 10% relative humidity and with a 12-h 
light/12-h dark cycle (lights on at 8:00 AM).  This study was carried out in 
accordance with the Guidelines for Animal Experiments at Okayama 
University Advanced Science Research Center, Japanese Government 
Animal Protection and Management Law (No. 115) and Japanese 
Government Notification on Feeding and Safekeeping of Animals (No. 6). 
Every effort was made to minimize the number of animals used and their 
suffering.  All experiments conformed to international guidelines on the 
ethical use of animals. 
 
Animal treatments and experimental protocols 
After anesthesia with sodium pentobarbital (50 mg/kg, intraperitoneally), 
an abdominal midline incision was made in the animal, and the superior 
mesenteric artery proximal to bifurcation from the abdominal aorta was 
carefully exposed and topically swabbed with 10% phenol solution (in 90% 
alcohol-saline) using a cotton bud.  Sham-operated rats underwent the 
same surgical procedures, except for swabbing with vehicle (saline or 90% 
alcohol without including phenol) instead of phenol solution.  After the 
swabbing, a mini-osmotic pump (model 2001, Alzet, Alza, Palp Alto, CA, 
USA) was implanted in the abdominal area to administer human 
recombinant Ang II (Peptide Institute, Osaka, Japan) at a rate of 60 
μg/kg/day, PD123,319 (Sigma Aldrich Japan, Tokyo, Japan) at a rate of 10 
mg/kg/day or NGF (Sigma Aldrich Japan) at a rate of 20 μg/kg/day for a 
period of 7 days.  Ang II, PD123,319 and NGF were dissolved in sterile 
saline and injected into Alzet mini-osmotic pumps.  Losartan (Merck & 
Co., Inc., Rahway, USA) was dissolved in drinking water at a concentration 
of 0.025 %.  Control animals were implanted with mini-osmotic pumps 
containing sterile saline alone.  Ang II at a dose of 60 μg/kg/day was 
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administered, which increased the systolic blood pressure.  The doses of 
losartan and NGF and PD123,319 were used according to our previous 
reports (Hobara et al., 2005 and 2006) and the report described by Jones et 
al. (2004), respectively.  After the swabbing and implanting, an antibiotic 
(penicillin G; Sigma Aldrich Japan) was infused around the surgical area 
and then the incision was closed.  To examine the influence of the 
operation, sham-operated rats underwent the same surgical procedures, 
except for swabbing with vehicle (saline or 90% alcohol without phenol) 
instead of phenol solution.  After the operation, the animals were 
transferred into individual cages in the temperature-controlled room and 
received intramuscular injection of penicillin G (3.1 mg/kg) for 3 
consecutive days.  After phenol treatment and sham operation, the animals 
were killed by deep anesthesia on Day 7 for use in the experiments 
described below. 
The animals were randomly divided into six groups: (1) normal control 
group (Sham); (2) phenol-saline group (Ph + Saline), animals receiving 
saline after phenol treatment; (3) phenol-Ang II group (Ph + Ang II), 
animals receiving Ang II after phenol treatment; (4) phenol-Ang II-losartan 
group (Ph + Ang II + Los), animals receiving both Ang II and losartan after 
phenol treatment; (5) phenol-Ang II-losartan-PD123,319 group (Ph + Ang 
II + Los + PD), animals concomitantly receiving Ang II, losartan and 
PD123,319 after phenol treatment; (6) phenol-NGF group (Ph +NGF), 
animals receiving NGF after phenol treatment. 
 
Systolic blood pressure measurement 
The systolic blood pressure of each animal was measured daily by 
tail-cuff plethysmography (model TK-370C; UNICOM, Tokyo, Japan) 
throughout the treatment period. 
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Immunohistochemical study 
The animals treated topically with phenol or vehicle were anesthetized 
with a large dose of sodium pentobarbital (50 mg/kg, intraperitoneally).  
The superior mesenteric artery was cannulated with polyethylene tubing 
and Zamboni solution (2% paraformaldehyde and 15% picric acid in 0.15 
M phosphate buffer) was infused, and the mesenteric artery was removed 
together with the intestine as described previously (Hobara et al., 2005, 
2006).  The third branch of the mesenteric artery proximal to the intestine 
was removed and immersion-fixed in the Zamboni solution for 48 h.  
After fixation, the artery was repeatedly rinsed in phosphate-buffered saline 
(PBS), immersed in PBS containing 0.5% TritonX-100 overnight, and 
incubated with PBS containing normal goat serum (1: 100) for 60 min.  
The tissue was then incubated with rabbit polyclonal anti-CGRP 
(Biogenesis Ltd., Oxford, UK) antiserum at a dilution of 1:300 or rabbit 
polyclonal anti-NPY (Phoenix Pharmaceuticals INC., Belmont, CA, 
U.S.A.) antiserum at a dilution of 1:300 for 72 h at 4ºC.  After the 
incubation, the artery was washed in PBS and the sites of antigen-antibody 
reaction were detected by incubation with fluorescein-5-isothiocyanate 
(FITC)-labeled goat anti-rabbit IgG (diluted 1: 100) (ICN Pharmaceuticals, 
Inc., Aurora, OH, USA) for 60 min.  Thereafter, the artery was thoroughly 
washed in PBS, mounted on a slide, cover-slipped with glycerol/PBS (2: 1 
v/v) and observed under a confocal laser scanning microscope (CLSM510, 
Carl Zeiss, Tokyo, Japan) in Okayama University Medical School Central 
Research Laboratory. 
   
Immunohistochemical analysis 
The immunostaining density of CGRP-like immunoreactive (CGRP-LI) 
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and NPY-like immunoreactive (NPY-LI) nerve fibers was analyzed using 
the method described by Hobara et al. (2005 and 2006).  Since the 
fluorescence intensity differed depending on the day of the experiment, the 
mesenteric arteries from rats treated with each drug after topical phenol 
treatment on Day 7 and vehicle-treated control rats were isolated, fixed and 
immunostained at the same time on the same day and mounted on the same 
slide glass, and the vehicle-treated rats at Day 7 were used as a control for 
the intensity in each experiment.  For quantitative evaluation of CGRP-LI 
and NPY-LI, confocal projection images of CGRP and NPY 
immunostaining, which consisted of 8-10 overlapping images (0.1 µm 
scanning) patched together, were magnified 20x and digitized as TIF 
images using a digital camera system (Olympus SP-1000, Olympus, Tokyo, 
Japan) and imported into a Windows XP computer (Toshiba, Tokyo, Japan).  
The stored digital images were analyzed using image-processing software 
(Simple PCI; Compix Inc., Imaging Systems, Cranberry Township, PA, 
USA).  The extraction of specific color and measured field commands 
were used to extract the CGRP-LI and NPY-LI areas (which were stained 
green).  Extraction of the signal was carried out using specific protocols 
based on the hue, lightness, and saturation color parameters.  A measured 
field of 100 μm x 100 μm (10000 μm2, which contained the adventitia layer 
including immunostained perivascular nerve fibers, was randomly selected 
on magnified images of the whole mount artery.  The objective areas 
command was used to calculate the percentage of CGRP-LI- and 
NPY-LI-positive area.  The intensity of staining was estimated using a 
point-counting computer program and the background level was subtracted 
from the experimental value to yield the corrected intensity.  The average 
of the density in three arteries was taken as the nerve density per animal.   
To determine the number of CGRP-LI and NPY-LI fibers, five 
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horizontal lines were drawn on the image of the blood vessel in the same 
region where the density was estimated by computer analysis.  Then, the 
number of fibers that crossed each line was counted and the average of the 
number in 3 arteries was taken as the total number of fibers per animal. 
 
Perfusion of mesenteric vascular beds 
The animals were anesthetized with sodium pentobarbital (50 mg/kg, 
intraperitoneally) and the mesenteric vascular bed was isolated and 
prepared for perfusion as described previously (Kawasaki et al., 1988, 
1990a).  The superior mesenteric artery was cannulated and flushed gently 
with a modified (see below) Krebs-Ringer bicarbonate solution (Krebs 
solution) to eliminate blood in the vascular bed.  After removal of the 
entire intestine and associated vascular bed, the mesenteric vascular bed 
was separated from the intestine by cutting close to the intestinal wall.  
Only four main arterial branches from the superior mesenteric trunk 
running to the terminal ileum were perfused.  All other branches of the 
superior mesenteric artery were tied off.  The isolated mesenteric vascular 
bed was then placed on a water-jacketed organ bath maintained at 37°C and 
perfused with Krebs solution at a constant flow rate of 5 ml/min with a 
peristaltic pump (model AC-2120, ATTO Co., Tokyo, Japan).  The 
preparation was also superfused with the same solution at a rate of 0.5 
ml/min to prevent drying.  The Krebs solution was bubbled with a mixture 
of 95% O2 plus 5% CO2 before passage through a warming coil maintained 
at 37°C.  The modified Krebs solution had the following composition 
(mM): NaCl 119.0, KCl 4.7, CaCl2 2.4, MgSO4 1.2, NaHCO3 25.0, 
KH2PO4 1.2, EDTA-2Na 0.03, and glucose 11.1 (pH 7.4).  Changes in the 
perfusion pressure were measured with a pressure transducer (model 
TP-400T, Nihon Kohden, Tokyo, Japan) and recorded using a pen recorder 
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(model U-228, Nippon Denshi Kagaku, Tokyo, Japan). 
 
Perivascular nerve stimulation (PNS) and bolus injection of 
norepinephrine (NE) or CGRP 
After allowing the basal perfusion pressure to stabilize, the preparation 
was initially subjected to PNS at 8 and 12 Hz and bolus injections of NE (5 
and 10 nmol), and then was contracted with α1-adrenoceptor agonist 
methoxamine (7 µM) in the presence of an adrenergic neuron blocker, 
guanethidine (5 µM), which was added to block the adrenergic 
neurotransmission.  The increased perfusion pressure was allowed to 
stabilize, and the preparation was again subjected to PNS at 1, 2 and 4 Hz 
and bolus injection of CGRP (25, 50 and 100 pmol).  PNS was applied by 
using bipolar platinum ring electrodes placed around the superior 
mesenteric artery.  Rectangular pulses of 1 ms and supramaximal voltage 
(50 V) were given for 30 s using an electronic stimulator (model SEN 3301, 
Nihon Kohden).  NE and CGRP were injected directly into the perfusate 
proximal to the arterial cannula with an infusion pump.  A volume of 100 
μL was injected for 12 s.   
At the end of each experiment, preparations were perfused with 100 µM 
papaverine to cause complete relaxation.  Vasodilator activity is expressed 
as the percentage of the perfusion pressure at the maximum relaxation 
induced by papaverine.  Vasoconstrictor activity is expressed as the 
percentage of the perfusion pressure. 
 
Western blot analysis of AT2 receptor protein 
The DRG was homogenized with scissors in 300 μl of Tris-buffered 
saline (20 mM Tris HCl (pH 7.4), 1 mM EDTA) containing protease 
inhibitor cocktail (Biovision Research Products, Mountain View, CA, 
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USA).  The homogenate was centrifuged at 600 g for 10 min at 4°C.  
The supernatant was further centrifuged at 100,000 g for 1 h at 4°C.  The 
resulting pellet was then washed and resuspended with the same 
Tris-buffered saline with 0.1 % Triton-X.  The solution was centrifuged at 
100,000 g for 1 h at 4 °C.  The concentration of protein in homogenate 
was determined using Bio-Rad protein assay solution (Bio-Rad 
Laboratories, Inc., Osaka, Japan) with bovine serum albumin as a standard.  
For Western blotting, membrane proteins were electrophoresed on a 
standard 12 % sodium deodecyl sulfate (SDS)-polyacrylamide gel 
(Bio-Rad Laboratories) in Tris-glycine electrophoresis buffer (25 mM Tris, 
192 mM glycine (pH 8.3), and 0.1 % SDS).  Proteins were transferred 
onto a Hybond-P membrane (Amersham Biosciences, Buckinghamshire, 
UK) in 192 mM glycine, 25 mM Tris (pH 8.3), and 30 % methanol at 100 v 
for 1.5 h.  The membrane was blocked in a blocking buffer (PBS 
containing 10% goat serum and 0.01M EDTA) at room temperature for 1 h.  
The membrane was then probed overnight at 4 °C with polyclonal antibody 
against AT2 receptor (Alpha Diagnostic International, San Antonio, TX, 
USA) (1:1000) or polyclonal antibody against β-actin (Cell Signaling 
Technology, Inc, Danvers, MA, USA) (1:2000) in the blocking buffer.  
After the membrane was washed five times in PBS it was incubated with 
goat anti-rabbit IgG conjugated with horseradish peroxidase (1:1000; R&D 
Systems, Inc., Minneapolis, MN, USA) in the blocking buffer for 1 h at 
room temperature.  Bound antibodies were detected using a 
chemiluminescent substrate kit (Amersham Biogensesis) and the content of 
β-actin was used as a control to ensure that the same amount of protein was 
loaded in each lane. 
 
Reagents 
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The following drugs were used: losartan (Merck & Co., Inc., Rahway, 
NJ, USA), NGF (Sigma Aldrich Japan), PD123,319 (Sigma Aldrich Japan) 
and penicillin G (Sigma Aldrich Japan), Ang II (Peptide Institute, INC., 
Osaka, Japan). 
 
Statistical Analysis 
All data are expressed as mean ± S.E.M.  Analysis of variance 
(ANOVA) followed by the Tukey’s test was used to determine statistical 
significance where appropriate.  Correlation analysis was carried out by 
using Pearson’s correlation test.  A value of p<0.05 was considered 
statistically significant. 
 
RESULTS 
 
Changes in systolic blood pressure (SBP) after phenol treatment  
Fig. 1 shows the tail-cuff systolic blood pressure in the six groups for 7 
days after topical phenol or vehicle (Sham) treatment.  The Ang II group 
(Ph + Ang II) showed significantly increased blood pressure from 4 days 
after Ang II administration compared with the saline control group (Ph + 
saline).  Losartan administration (Ang II + Los and Ang II + Los + PD) 
completely inhibited the increase of blood pressure induced by Ang II.   
 
Changes in innervation of CGRP-LI nerve fibers in mesenteric arteries 
following topical phenol treatment with or without administration of each 
drug  
Fig. 2 and Fig. 3 show typical images of innervation of CGRP-LI nerves 
and changes in the density of CGRP-LI nerve fibers in the mesenteric 
artery after topical treatment with phenol and 7-day treatment with each 
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drug, respectively.  As shown in Fig. 2A, the distal small mesenteric 
artery from the Sham group, which was treated topically with vehicle 
(saline or 90% alcohol solution without phenol) on the superior mesenteric 
artery, had dense innervation of CGRP-LI nerves.  Topical application of 
phenol on the superior mesenteric artery, as shown in Fig. 2B, caused a 
marked reduction of innervation of CGRP-LI nerve fibers in the distal 
small mesenteric artery.  The density of CGRP-LI nerve fibers in the 
phenol-saline-treated group was significantly decreased to approximately 
20% of that in the Sham group (Fig. 3). 
Administration of Ang II caused a 20% increase in the density of 
CGRP-LI nerve fibers, but no significant difference was found between the 
Ang II group and phenol-saline group, as shown in Fig. 2C and Fig. 3.  
Combined administration of Ang II and an AT1 receptor antagonist, 
losartan, (Ph + Ang II + Los) after topical phenol treatment significantly 
elevated the density of CGRP-LI nerve fibers compared with that in the 
phenol-saline group (Ph + saline) (Fig. 2D and Fig. 3).  However, when 
PD123,319, an AT2 receptor antagonist, was combined with Ang II and 
losartan (Ph + Ang II + Los + PD), the density of CGRP-LI nerve fibers 
decreased to a level similar to that in the phenol-saline group (Fig. 2E and 
Fig. 3). 
The relationships between the numbers of CGRP-LI nerve fibers, which 
were counted visually, and the densities of CGRP-LI nerves (%), which 
were quantified by computer-assisted image processing, were assessed in 
the mesenteric arteries of all groups.  There were significant positive 
correlations between the density and the numbers of CGRP-LI nerve fibers 
in the Sham (p<0.01, r = 0.801), phenol + saline (p<0.01, r = 0.943), phenol 
+ Ang II (p<0.01 r = 0.833), phenol + Ang II + losartan (p<0.01, r = 0.890), 
and phenol + Ang II + losartan + PD123,319 (p<0.01, r = 0.859) groups 
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(data not shown). 
 
Changes in innervation of NPY-LI nerve fibers in mesenteric arteries 
following topical phenol treatment with or without administration of each 
drug  
Fig. 4 and Fig. 5 show typical images of innervation of NPY-LI nerves 
and changes in the density of NPY-LI nerve fibers in the mesenteric artery 
after topical treatment with phenol and 7-day treatment with each drug, 
respectively.  As shown in Fig. 4A, the distal small mesenteric artery from 
the Sham group had denser innervation of NPY-LI nerves than CGRP-LI 
nerve fibers.  Topical phenol application on the superior mesenteric artery 
reduced innervation of NPY-LI nerve fibers in the distal small mesenteric 
artery (Fig. 4B).  The density of NPY-LI nerve fibers in the phenol-saline 
treated group was significantly decreased to approximately 50% of that in 
the sham group (Fig. 5). 
Administration of Ang II after phenol treatment caused approximately a 
15% increase in the density of NPY-LI nerve fibers, but no significant 
difference was found between this group and the phenol-saline group, as 
shown in Fig. 4C and Fig. 5.  Combined administration of Ang II and 
losartan (Ph + Ang II + Los) or Ang II, losartan and PD123,319 (Ph + Ang 
II + Los + PD) after topical phenol treatment did not significantly affect the 
density of NPY-LI nerve fibers compared with that in the phenol-saline 
group (Ph + saline) (Fig. 4D, Fig. 4E and Fig. 5). 
The relationships between the numbers of NPY-LI nerve fibers, which 
were counted visually, and the densities of NPY-LI nerves (%), which were 
quantified by computer-assisted image processing, were assessed in the 
mesenteric arteries of all groups.  There were significant positive 
correlations between the density and the numbers of NPY-LI nerve fibers in 
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the Sham (p<0.01, r = 0.728), phenol + saline (p<0.01, r = 0.827), phenol + 
Ang II (p<0.01 r = 0.595), phenol + Ang II + losartan (p<0.01, r = 0.849) 
and phenol + Ang II + losartan + PD123,319 (p<0.01, r = 0.889) groups 
(data not shown). 
 
Effect of NGF on changes in innervation of CGRP-LI and NPY-LI nerve 
fibers in mesenteric arteries following topical phenol treatment 
The administration of NGF after topical phenol administration markedly 
elevated the density of both CGRP-LI (Fig. 2F and Fig. 3) and NPY-LI 
nerve fibers (Fig. 4F and Fig. 5) to levels similar to those in the Sham 
group.  There were significant differences in the densities of CGRP-LI 
nerve fibers between the phenol-NGF group and phenol-saline group, 
phenol-Ang II group or phenol-Ang II-losartan-PD123,319 group but not 
phenol-Ang II-losartan group.  Also, there were significant differences in 
the densities of NPY-LI nerve fibers between the phenol-NGF group and 
phenol-saline group, phenol-Ang II group or phenol-Ang II-losartan group 
but not phenol-Ang II-losartan-PD123,319 group. 
The relationships between the numbers of CGRP-LI and NPY-LI nerve 
fibers, which were counted visually, and the densities of CGRP-LI and 
NPY-LI nerves (%), which were quantified by computer-assisted image 
processing, were assessed in the mesenteric arteries of all groups.  There 
were significant positive correlations between the density and the numbers 
of CGRP-LI and NPY-LI nerve fibers on phenol + NGF group (CGRP-LI, 
p<0.01 r = 0.715; NPY-LI, p<0.05, r = 0.632) (data not shown).  
 
Changes in vasoconstrictor responses to PNS or bolus injection of NE  
Fig. 6A shows typical vascular responses induced by PNS and 
vasoactive agents in a perfused mesenteric vascular preparation from a 
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Sham rat.  As shown in Fig. 6a, PNS (8 and 12 Hz) of the perfused 
mesenteric vascular beds with resting tone produced a frequency-dependent 
increase in perfusion pressure due to vasoconstriction.  The PNS-induced 
vasoconstriction was abolished by α1-adrenoceptor antagonist (prazosin) 
and adrenergic neuron blocker (guanethidine) (data not shown), indicating 
that the response was mediated by NE released due to stimulation of 
periarterial adrenergic nerves.  Bolus injections of NE at concentrations of 
5 and 10 nmol also caused concentration-dependent vasoconstriction (Fig. 
6b), which was blocked by prazosin but not guanethidine (data not shown), 
indicating that the response was mediated by stimulation of postsynaptic 
α1-adrenoceptors. 
As shown in Fig. 6B and Fig. 7A, the vasoconstrictor responses to PNS 
at 12 Hz but not 8 Hz in phenol-saline group were significantly smaller 
than those in the Sham group.  Administration of Ang II after phenol 
treatment significantly increased the PNS-induced vasoconstrictor 
responses at 8 and 12 Hz compared with phenol-saline group.  Combined 
administration of Ang II and losartan significantly decreased the 
PNS-induced vasoconstriction in the Phenol-Ang II group and addition of 
PD123,319 in Ang II and losartan caused a further significant decrease in 
the vasoconstrictor responses to PNS (8 and 12 Hz) in phenol-Ang II group. 
No significant change was found between the PNS-induced responses in 
phenol-NGF group and sham group.   
Vasoconstrictor response to exogenous NE injection (5 nmol) in 
phenol-Ang II groups was significantly greater than those in sham group 
and phenol-Ang II group.  The increased vasoconstrictor response to NE 
injection at 5 nmol but not 10 nmol was inhibited by coadministration of 
pheno-l-Ang II-losartan and PD123,319.  The vasoconstriction induced by 
10 nmol NE injection in phenol-Ang II-losartan group was greater than 
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those in sham, phenol-saline, phenol-Ang II-losartan-PD123,319 and 
phenol-NGF groups.  However, significant difference was found between 
the phenol-Ang II-losartan group and phenol-NGF group (Fig. 7B).   
 
Changes in vasodilator responses to PNS or bolus injection of CGRP  
To observe vasodilation, active tone of the mesenteric artery was 
produced by continuous perfusion of 7 µM methoxamine (α1-adrenergic 
receptor agonist) in the presence of 5 µM guanethidine (adrenergic neuron 
blocker), which was added to block adrenergic neurotransmission.  In this 
preparation, PNS at 1, 2 and 4 Hz caused a frequency-dependent decrease 
in perfusion pressure due to vasodilation, as shown in Fig. 6c.  The 
vasodilator response to PNS has been shown to be mediated by CGRPergic 
nerves, since the response was blocked by CGRP receptor antagonist 
(CGRP(8-37)) and CGRP depletor (capsaicin) (Kawasaki et al., 1990a).  
Bolus injections of CGRP also induced concentration-dependent 
vasodilation (Fig. 6d), which has been shown to be mediated by 
postsynaptic CGRP receptors (Kawasaki et al., 1990a).  
The vasodilation in response to PNS at 2 and 4 Hz but not 1 Hz in 
phenol-saline, phenol-Ang II and phenol-Ang II-Losartan-PD123,319 
groups but not in phenol-Ang II-losartan and phenol-NGF groups was 
significantly smaller than that in the sham group (Fig. 6B and Fig. 8A).  
The PNS (2 Hz)-response in phenol-NGF group was significantly greater 
than that in phenol-saline group. 
As shown in Fig. 8B, vasodilation induced by exogenous CGRP 
injection at 25-100 pmol did not significantly alter after various treatments 
except phenol-NGF treatment.  The vasodilation induced by 50 and 100 
pmol CGRP but not 25 pmol in phenol-NGF group was significantly 
smaller than those in sham group, phenol-Ang II-losartan group and 
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phenol-saline group (100 pmol CGRP).  
 
Western blot analysis 
To investigate changes in AT2 receptor expression at Day 7 after topical 
phenol treatment, Western blot analysis was performed.  As shown in Fig. 
9, AT2 receptors, which were detected as membrane proteins of 45 kDa 
molecular weight, were detected in the DRG of the Sham group.  Saline or 
Ang II administration after topical phenol treatment did not affect the AT2 
receptor expression.  Combined treatment with Ang II and losartan after 
phenol treatment tended to decrease or increase the AT2 receptor 
expression to less than the control level.  Combination of Ang II, losartan 
and PD123,319 treatment after phenol treatment tended to increase the AT2 
receptor expression to greater than the control level.  However, no 
significant difference was found between the expression in the 
phenol-saline group and phenol-Ang II-losartan group or phenol-Ang 
II-losartan-PD123,319 group.  In the phenol-NGF-treated group, AT2 
receptor expression was significantly greater than that in the Sham group. 
 
DISCUSSION 
 
The present study is the first to demonstrate that activation of AT2 
receptors facilitates reinnervation of perivascular CGRP-LI nerves, but not 
NPY-LI nerves, in the rat mesenteric artery, that was lesioned by topical 
application of phenol.  Our recent report showed evidence that topical 
treatment with phenol around the rat superior mesenteric artery induced a 
marked reduction of innervation of perivascular NPY- and 
CGRP-containing nerves in the distal small artery (Hobara et al., 2006).  
Additionally, in this report, we have shown evidence that NGF treatment 
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for 7 days immediately after phenol application restored the reduction of 
innervation of perivascular CGRP-LI and NPY-LI nerves to the control 
level (Hobara et al., 2006).  These findings were further confirmed by the 
finding in the present study that topical phenol application reduced the 
density of perivascular NPY-LI and CGRP-LI nerve fibers in the 
mesenteric artery, and these reductions were prevented by NGF treatment.  
In the present study, the selective AT1 receptor blocker losartan was 
used to selectively stimulate AT2 receptors, since administration of Ang II 
in the presence of losartan results in stimulation of only AT2 receptors due 
to blockade of AT1 receptors.  This notion was supported by the present 
finding that continuous infusion of Ang II caused an increase in the SBP of 
phenol-treated rats, and this hypertensive effect was completely eliminated 
by the addition of losartan, suggesting that Ang II could not stimulate AT1 
receptors in the presence of losartan but that the peptide might stimulate 
AT2 receptors.  This AT2 receptor stimulation employed in the present 
study resulted in a significant increase in the innervation of CGRP-LI 
nerves that had been markedly reduced by topical phenol treatment, 
whereas AT2 receptor stimulation did not affect the phenol-induced 
decrease in the NPY-LI nerve innervation.  Furthermore, the facilitatory 
effect of AT2 receptor stimulation on the innervation of CGRP-LI nerves 
was abolished by the addition of the AT2 receptor antagonist together with 
Ang II and losartan, suggesting the involvement of AT2 receptors in the 
regeneration and/or redistribution of lesioned CGRP-LI nerve fibers.  
Thus, it is very likely that AT2 receptors play an important role in the 
reinnervation of perivascular CGRP-containing nerves that have been 
damaged by phenol application. 
CGRP is well known to be a vasodilator neurotransmitter (Kawasaki et 
al., 1988).  When perivascular CGRP nerves are electrically stimulated, 
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neurotransmitter CGRP is released from the nerves and activates CGRP 
receptors on vascular smooth muscle cells, causing vasodilatation 
(Kawasaki et al., 1988, 1990a).  As shown in the present study, the 
PNS-induced vasodilatation of the precontracted mesenteric artery under 
the blockade of adrenergic neurotransmission results from CGRP released 
from CGRP nerves that innervate the mesenteric artery.  The present 
finding that the vasodilator response to PNS decreased after phenol 
treatment was likely due to the loss of CGRP-LI nerve fibers.  Combined 
treatment with Ang II and losartan (phenol-Ang II-losartan-treated group), 
which could stimulate AT2 receptors, caused greater vasodilator responses 
to 2 and 4 Hz PNS than those in the phenol-saline and phenol-Ang II 
groups and resulted in responses that were not significantly different from 
those in the Sham group, while the responses in the phenol-saline and 
phenol-Ang II-treated group were significantly smaller than that in the 
Sham group.  Furthermore, the addition of AT2 receptor antagonist 
PD123,319 along with Ang II and losartan treatment caused significantly 
decreased vasodilatation in response to PNS, to a level similar to that in the 
phenol-saline-treated group.  Taken together, these findings suggest that 
AT2 receptors have the ability to facilitate the process of reinnervation of 
CGRP-LI nerve fibers. 
In the present study, the AT1 and AT2 receptor agonist Ang II caused a 
slight (but not significant) increase in the density of NPY-LI and CGRP-LI 
nerve fibers in the phenol-treated mesenteric artery.  Lucius et al. (1998) 
reported that treatment with Ang II or Ang II plus losartan induces nerve 
regeneration in the retinal ganglion cells.  However, in the present study, 
AT2 receptor stimulation following phenol treatment resulted in 
maintenance of a level similar to the density of NPY-LI nerve fibers and 
adrenergic (NPY-containing) nerve-mediated vasoconstriction in response 
Hobara et al  Page 22 
to PNS in the phenol-lesioned group, while the stimulation facilitated 
reinnervation of CGRP-LI nerves.  These findings suggest that AT2 
receptors may act to inhibit reinnervation of NPY-LI nerve fibers.  This 
may explain why Ang II alone could not facilitate the reinnervation of 
NPY-LI nerve fibers in the phenol-treated mesenteric artery.  Furthermore, 
based on the present findings, the following two possibilities should be 
considered; 1) stimulation of AT1 receptors inhibits reinnervation of 
CGRP-LI nerves and stimulation of both AT1 and AT2 receptors by Ang II 
produces functions to an equal extent in opposite directions each other; 2) 
stimulation of AT1 receptors produces no effect on reinnervation of 
CGRP-LI nerves, but AT1 receptors are abundantly expressed or have 
higher affinity to Ang II, compared to AT2 receptors.  
NPY has been shown to be co-localized with the neurotransmitter NE 
in the granules of adrenergic nerves (Fried et al., 1985).  Ang II evokes 
the release of NPY and NE, thereby facilitating adrenergic 
neurotransmission (Claudia et al., 2003).  In contrast, Ang II inhibits the 
release of CGRP, thereby inhibiting neurotransmission in CGRP-containing 
nerves (Kawasaki et al., 1998).  Therefore, it seems likely that the 
augmented vasoconstrictor response to PNS in Ang II-treated group was 
due to the facilitatory effect of Ang II on adrenergic nerve function. 
Studies with Western blot and RT-PCR analysis have shown that AT2 
receptors are localized in endothelial cells and smooth muscle cells in rat 
mesenteric arteries (Matrougui et al., 1999) and skeletal muscle arterioles 
(Nora et al., 1998).  The AT2 receptors in the central nervous system 
(CNS) have been reported to be distributed in the hippocampus, limbic 
structures, thalamic area and hypothalamic areas (Reagan et al., 1994).  
Additionally, mRNA expression of AT2 receptors has been detected in the 
lateral septum, several thalamic nuclei and the inferior olive in the rat adult 
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brain (Lenkei et al., 1996).  Furthermore, the mRNA of AT2 receptors in 
the lateral septum of the rat adult brain is expressed in neurons rather than 
glial cells (Lenkei et al., 1996).  In the present study, Western blot analysis 
showed that AT2 receptors were detected in the DRG, which contains the 
cell bodies of the sensory afferent neurons and is a prominent site of CGRP 
synthesis.  Thus, these findings support the notion that stimulation of AT2 
receptors facilitates reinnervation of CGRP-LI nerves.  The different 
effects of AT2 receptor stimulation on the reinnervation of CGRP-LI and 
NPY-LI nerves may be due to the different distributions of AT2 receptors.  
Nap et al. (2003) reported that Ang II enhances sympathetic 
neurotransmission via AT1 receptors located on sympathetic nerve 
terminals, but AT2 receptors did not enhance sympathetic 
neurotransmission in vitro.  Therefore, it is assumed that the sympathetic 
ganglion may have a lower density of AT2 receptors.  In the present study, 
decreased expression of AT2 receptors was observed in the DRG after 
phenol-Ang II-losartan treatment, which stimulates AT2 receptors, 
suggesting down-regulation of the expression of AT2 receptors due to their 
continuous stimulation.  In contrast, blockade of AT2 receptors in 
Phenol-Ang II-Losartan-PD123,319 group tended to increase AT2 receptor 
expression, although no significance was found.  These results suggest 
that stimulation and/or blockade of AT2 receptor function may result in 
down- or up-regulation of AT2 receptor expression in DRG.  Furthermore, 
it seems likely that stimulation of AT1 receptors causes the increase in 
expression of AT2 receptors, which counteract down-regulation induced by 
stimulation of AT2 receptors.  This may explain the finding that Ang II 
treatment alone tended to increase the expression of AT2 receptors.  Since 
AT1 receptors are abundantly distributed, Ang II activates predominantly 
AT1 receptors to mask the function of AT2 receptor.  In accord with this 
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notion, it has been reported that Ang II-infused rats showed an increase in 
the mRNA of vascular AT2 receptors, but coadministration of Ang II with 
valsartan, an AT1 receptor blocker, decreased the AT2 receptor mRNA 
expression (Bonnet et al., 2001).  Therefore, it seems likely that the AT2 
receptor expression may be correlated with the presence of AT1 receptors. 
It should be noted that treatment with NGF significantly increased AT2 
receptor protein expression in the DRG of phenol-treated rats.  Since NGF 
treatment could restore the phenol-induced reduction of the density of 
CGRP-LI and NPY-LI nerve fibers to the control level, it is very likely that 
AT2 receptors play a critical role in the action of NGF.  NGF has been 
shown to regulate the mRNA expression of AT2 receptors in neurons 
derived from the neonatal rat brainstem and hypothalamus (Huang et al., 
1997).  Additionally, it was reported that AT2 receptors promote neuronal 
differentiation (Lucius et al., 1998).  On the other hand, AT2 receptors 
induce apoptosis to inactivate Bcl-2, which is an antiapoptotic protein 
(Horiuchi et al., 1997).  Therefore, further studies are needed to clarify 
whether an increase of AT2 receptor expression is responsible for the 
neurotrophic and neuroprotective effects of NGF. 
In conclusion, the present study suggests that AT2 receptors play an 
important role in the process of regeneration of CGRPergic nerves, which 
innervate mesenteric resistance arteries of the rat.  We have reported that 
CGRPergic nerve innervation in SHR decreases with age and that 
long-term administration of AT1 receptor antagonist in SHR prevents the 
age-related decreases in function and distribution of CGRPergic nerves 
(Kawasaki et al., 1990b, Hobara et al., 2005).  Therefore, we hypothesize 
that AT1 receptor antagonists may exert hypotensive effects not only by 
inhibiting the AT1 receptor-mediated effect of Ang II but also by activating 
AT2 receptors to prevent remodeling of CGRPergic nerves and facilitate 
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reinnervation of CGRPergic nerve fibers. 
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Figure legends 
Fig. 1.  Changes in systolic blood pressure following topical phenol 
treatment.  Numbers of animals in each group were as follows: Sham (n = 
6); Phenol + saline (n = 5); Phenol + Angiotensin II (750 ng/kg/min) (n = 
7); Phenol + Angiotensin II + losartan (0.025% dissolved in drinking water) 
(n = 7); Phenol + Angiotensin II + losartan + PD123,319 (10 mg/kg/day) (n 
= 5).  Data are mean ± S.E.M.  *p<0.05 vs. Sham control.  †p<0.05 vs 
Phenol + Ang II group 
 
Fig. 2.  Representative confocal laser micrographs showing changes in the 
density of calcitonin gene-related peptide (CGRP)-like immunoreactive 
(LI)-containing nerve fibers in mesenteric arteries 7 days after topical 
phenol treatment and administration of saline (saline), angiotensin II (Ang 
II), coadministration of angiotensin II with losartan (Ang II + Los), 
coadministration of angiotensin II with losartan and PD123,319 (Ang II + 
Los +PD) or nerve growth factor (NGF).  The horizontal bar in the right 
lower corner of each panel indicates 100 µm.   
 
Fig. 3.  Changes in density of CGRP-containing nerve fibers in distal 
mesenteric arteries after topical phenol treatment of the superior mesenteric 
artery and administration of saline (saline) (n = 5), angiotensin II (Ang II) 
(n = 7), coadministration of angiotensin II with losartan (Ang II + Los) (n = 
7), coadministration of angiotensin II with losartan and PD123,319 (Ang II 
+ Los +PD) (n = 5), or nerve growth factor (NGF) (n = 5).  Sham (n = 6) 
indicates treatment of the superior mesenteric artery with saline instead of 
phenol.  *p<0.01 vs. Sham control.  †p<0.05 vs. phenol-NGF.  Each bar 
indicates mean ± S.E.M. 
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Fig. 4.  Representative confocal laser micrographs showing changes in the 
density of neuropeptide Y (NPY)-like immunoreactive (LI)-containing 
nerve fibers in mesenteric arteries 7 days after topical phenol treatment and 
administration of saline (saline), angiotensin II (Ang II), coadministration 
of angiotensin II with losartan (Ang II + Los), coadministration of 
angiotensin II with losartan and PD123,319 (Ang II + Los +PD) or nerve 
growth factor (NGF).  The horizontal bar in the right lower corner of each 
panel indicates 100 µm. 
 
Fig. 5  Changes in density of neuropeptide Y (NPY)-like immunoreactive 
(LI)-containing nerve fibers in distal mesenteric arteries after topical 
phenol treatment of the superior mesenteric artery and administration of 
saline (saline) (n = 5), angiotensin II (Ang II) (n = 7), coadministration of 
angiotensin II with losartan (Ang II + Los) (n = 7), coadministration of 
angiotensin II with losartan and PD123,319 (Ang II + Los +PD) (n = 5), or 
nerve growth factor (NGF) (n = 5).  Sham (n = 6) indicates treatment of 
the superior mesenteric artery with saline instead of phenol.  *p<0.01 vs 
Sham control.  †p<0.05 vs. phenol-NGF.  Each bar indicates mean ± 
S.E.M. 
 
Fig. 6.  Typical records showing vasoconstrictor responses induced by 
periarterial nerve stimulation (PNS) and bolus infusion of norepinephrine 
(NE, 5 and 10 nmol) and vasodilator responses induced by PNS and bolus 
injection of calcitonin gene-related peptide (CGRP, 25, 50 and 100 pmol) in 
perfused mesenteric vascular beds.  A; the preparation isolated from a 
Sham control rat.  B; vasoconstrictor and vasodilator responses in a 
preparation isolated from a phenol-saline-treated rat.  C; vasoconstrictor 
and vasodilator responses in a preparation isolated from a 
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phenol-angiotensin II (Ang II)-losartan (Los)-treated rat.  a and b; 
vasoconstrictor responses in the preparation with resting tone.  c and d: 
vasodilator responses in the preparation with active tone produced by 7 µM 
methoxamine in the presence of 5 µM guanethidine.  PPV; perfusion of 
papaverine. 
 
Fig. 7.  Changes in vasoconstrictor responses to perivascular nerve 
stimulation (PNS) and to bolus infusion of norepinephrine (NE) in perfused 
mesenteric vascular beds isolated from the Sham control (n = 7), Phenol + 
saline (n = 12), Phenol + Angiotensin II (Ang II; 750 ng/kg/day) (n= 6), 
Phenol + Angiotensin II (Ang II) + losartan (Los; 0.025 % dissolved in 
drinking water) (n = 7), Phenol + Angiotensin II (Ang II) + losartan (Los) + 
PD123,319 (PD; 10 mg/kg/day) (n = 5) and Phenol + NGF (NGF; 20 
μg/kg/day) (n = 4) groups.  *p<0.05 vs. Sham control.  Each bar 
indicates mean ± S.E.M. 
 
Fig. 8.  Changes in vasodilator responses to perivascular nerve stimulation 
(PNS) and to bolus infusion of calcitonin gene-related peptide (CGRP) in 
perfused mesenteric vascular beds isolated from group of Sham control (n 
= 10), Phenol + saline (n = 12), Phenol + Angiotensin II (Ang II; 750 
ng/kg/day) (n= 6), Phenol + Angiotensin II (Ang II) + losartan (Los; 
0.025 % dissolved in drinking water) (n = 7), Phenol + Angiotensin II (Ang 
II) + losartan (Los) + PD123,319 (PD; 10 mg/kg/day) (n = 5) and Phenol + 
NGF (NGF; 20 μg/kg/day) (n = 4) groups.  The active tone was produced 
by 7 µM methoxamine in the presence of 5 µM guanethidine.  Relaxation 
is expressed as the percentage of maximum relaxation induced by perfusion 
of 100μM papaverine at the end of each experiment.  *p<0.05 vs. Sham 
control.  Each bar indicates mean ± S.E.M. 
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Fig. 9.  Western blot analysis of angiotensin type 2 receptor (AT2 
receptor) protein expression in dorsal root ganglia (DRG) isolated from the 
Sham control (n = 3), Phenol + saline (n = 3), Phenol + nerve growth factor 
(NGF) (n = 3), Phenol + Angiotensin II (Ang II) + losartan (Los) (n = 3), 
Phenol + Ang II + losartan + PD123,319 (PD) (n = 3) and Phenol + Ang II 
(n = 4) groups.  Molecular weight of the AT2 receptor and β-actin proteins 
indicated in the upper right was about 45 kDa and 47 kDa, respectivdely.  
*p<0.05 vs. Sham control.  The ratio of the level of each test protein to 
β-actin was determined by densitometric analysis.  Each bar indicates 
mean ± S.E.M. 
